New England BioLabs, Inc.

United States of America

Back to Profile

1-100 of 460 for New England BioLabs, Inc. Sort by
Query
Aggregations
IP Type
        Patent 306
        Trademark 154
Jurisdiction
        United States 292
        World 137
        Canada 30
        Europe 1
Date
New (last 4 weeks) 3
2024 April (MTD) 1
2024 March 2
2023 December 5
2024 (YTD) 4
See more
IPC Class
C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids 97
C12N 9/22 - Ribonucleases 70
C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA 68
C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7) 59
C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides 56
See more
NICE Class
01 - Chemical and biological materials for industrial, scientific and agricultural use 134
42 - Scientific, technological and industrial services, research and design 31
09 - Scientific and electric apparatus and instruments 18
05 - Pharmaceutical, veterinary and sanitary products 15
35 - Advertising and business services 13
See more
Status
Pending 60
Registered / In Force 400
  1     2     3     ...     5        Next Page

1.

TRICAP

      
Serial Number 98484578
Status Pending
Filing Date 2024-04-04
Owner New England Biolabs, Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Nucleic acid products, namely, mRNA and mRNA capping reagents for scientific research Nucleic acid products, namely, mRNA and mRNA capping reagents for pharmaceutical purposes and medical purposes

2.

FUSER

      
Serial Number 98472886
Status Pending
Filing Date 2024-03-28
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Reagents for scientific and research use for molecular biology and cell biology applications; Enzymes for scientific and research use for molecular biology and cell biology applications; Reagents for scientific and research use for use in sequencing applications; Enzymes for scientific and research use for use in sequencing applications; Kits for use in sequencing applications comprised of reagents and enzymes for scientific use; Chemicals for use in industry and science; DNA polymerase, reagents and reagent kits comprising generic DNA circle, DNA polymerase and buffers for scientific, medical or veterinary research use; DNA polymerase, reagents and reagent kits comprising generic DNA circle, DNA primers, DNA polymerase and buffers for use in the biotechnology field

3.

METHODS FOR CHARACTERIZING AN IMMUNE RESPONSE REPERTOIRE

      
Application Number US2023074661
Publication Number 2024/064736
Status In Force
Filing Date 2023-09-20
Publication Date 2024-03-28
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Song, Chen
  • Erijman, Ariel
  • Lund, Sean
  • Langhorst, Bradley, W.
  • Liu, Pingfang

Abstract

This disclosure provides synthetic nucleic acid oligonucleotides and related methods for analysis of immune repertoires. A disclosed synthetic oligonucleotide contains (a) one or more tags with a sequence that is not contained in a eukaryotic immune repertoire, wherein at least one tag is positioned between a region corresponding to a diversity and joining region (( D)J) and a constant region (C) of an immunoglobulin (IG) or T cell receptor, thereby distinguishing the synthetic oligonucleotide from naturally occurring sequences in the eukaryotic immune repertoire; and wherein the V(D)J region has a predetermined V(D)J clonotype, the synthetic oligonucleotide optionally further comprising a tag proximate to a region corresponding to a eukaryotic variable region (V); and optionally wherein C further comprises one or more priming sites for nucleic acid amplification.

IPC Classes  ?

  • C12Q 1/6851 - Quantitative amplification
  • C12Q 1/6881 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes

4.

NEW ENGLAND BIOLABS MONARCH DNA & RNA PURIFICATION

      
Serial Number 98427591
Status Pending
Filing Date 2024-02-29
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Biological and biochemical reagents or kits for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; chemical products for commercial and scientific purposes, namely, chemicals or biochemicals for the isolation and purification of nucleic acids for scientific purposes and for use in polymerase chain reaction; all sold either individually or in kits

5.

LYOPRIME

      
Application Number 1768708
Status Registered
Filing Date 2023-11-06
Registration Date 2023-11-06
Owner New England Biolabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific research use; reagents for molecular biology and/or cell biology for scientific, research, laboratory or in vitro diagnostic use; reagents for diagnostic tests and/or diagnostic devices for scientific, research, laboratory or in vitro diagnostic use; reagents for genetic research, clinical or medical laboratory use; enzyme reagents for scientific, research, laboratory or in vitro diagnostic use; enzymes for scientific and/or research use; enzymes for molecular biology research and/or cell biology scientific and research applications.

6.

Vaccinia Capping Enzyme Compositions and Methods

      
Application Number 18462868
Status Pending
Filing Date 2023-09-07
First Publication Date 2023-12-28
Owner New England Biolabs, Inc. (USA)
Inventor
  • Vainauskas, Saulius
  • Chan, Siu-Hong
  • Taron, Christopher H.

Abstract

The present disclosure relates, according to some embodiments, to compositions, methods, and/or kits for producing vaccinia capping enzyme. For example, active, heterodimers of vaccinia capping enzyme may be produced as fusions comprising D1 and D12 subunits. Vaccinia capping enzyme fusion proteins may further comprise a linker.

IPC Classes  ?

  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

7.

FCE MRNA CAPPING ENZYME COMPOSITIONS, METHODS AND KITS

      
Application Number 18340083
Status Pending
Filing Date 2023-06-23
First Publication Date 2023-12-28
Owner New England Biolabs, Inc. (USA)
Inventor
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Christopher H.
  • Robb, G. Brett

Abstract

The present disclosure relates to compositions, kits, and methods of making RNA vaccines having an appropriate cap structure. Systems, apparatus, compositions, and/or methods may include and/or use, in some embodiments, non-naturally occurring single-chain RNA capping enzymes. In some embodiments, an RNA capping enzyme may include an FCE variant having (a) an amino acid sequence at least 90% identical to positions 1 to 878 of SEQ ID NO: 1, and/or (b) one or more substitutions relative to SEQ ID NO: 1 at a position selected from positions corresponding to positions 215, 337, 572, 648, and 833 (e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

IPC Classes  ?

  • C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 9/10 - Transferases (2.)
  • A61K 39/245 - Herpetoviridae, e.g. herpes simplex virus
  • C12N 7/00 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

8.

Rapid Diagnostic Test for LAMP

      
Application Number 18452104
Status Pending
Filing Date 2023-08-18
First Publication Date 2023-12-21
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine B.
  • Strimpel, Harriet M.
  • Correa, Jr., Ivan R.
  • Carlow, Clotilde
  • Slayton, Esta
  • Evans, Jr., Thomas C.

Abstract

Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The compositions and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The compositions and methods are directed to labelled probes and their uses in Loop-Mediated Isothermal Amplification (LAMP) diagnostic tests to detect target DNA from the environment or from an individual and also to detect specific variants of the target DNA, both with similar sensitivity. The compositions and methods may use any single improvement or combination of improvements selected from thermolabile enzyme variants, poloxamers, various salts, indicators and one or more LAMP primer sets for detecting single and/or multiple targets, probes for detecting variants of the targets including SARS-CoV-2 variants and lateral flow devices.

IPC Classes  ?

  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
  • G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour

9.

METHODS AND COMPOSITIONS FOR THE SIMULTANEOUS IDENTIFICATION AND MAPPING OF DNA METHYLATION

      
Application Number US2023068429
Publication Number 2023/245056
Status In Force
Filing Date 2023-06-14
Publication Date 2023-12-21
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Yan, Bo
  • Sun, Zhiyi
  • Vaisvila, Romualdas
  • Ettwiller, Laurence
  • Williams, Louise, Js
  • Ponnaluri, Chaithanya
  • Evanich, Daniel, J.
  • Panchapakesa, Vaishnavi

Abstract

Provided herein is a method for generating a strand of DNA. In some embodiments, this method may comprise: (a) ligating a hairpin adaptor to a double-stranded fragment of DNA to produce a ligation product; (b) enzymatically generating a free 3' end in a double-stranded region of the hairpin adaptor in the ligation product; and (c) extending the free 3' end in a dCTP-free reaction mix that comprises a strand-displacing or nick-translating polymerase, dGTP, dATP, dTTP and modified dCTP to generate a hairpin product that has an original strand and a neosynthesized strand that contains modified Cs.

IPC Classes  ?

10.

RNase inhibitors

      
Application Number 17207507
Grant Number 11827885
Status In Force
Filing Date 2021-03-19
First Publication Date 2023-11-28
Grant Date 2023-11-28
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Ong, Jennifer
  • Slayton, Esta
  • Maduzia, Lisa
  • Russello, Salvatore V.

Abstract

Compositions, methods and kits are provided that include an inhibitory oligonucleotide RNase inhibitor capable of inhibiting one or more types of RNase that coexist with biological samples or are introduced in the laboratory, thereby protecting RNA in the sample from degradation. More than one type of oligonucleotide RNase inhibitor may be combined in a mixture to inhibit a plurality of different RNases. Single oligonucleotides were identified to have inhibitory activity for a plurality of different RNases. The RNase oligonucleotide inhibitor may be immobilized on beads or other surface. It may be stored in a lyophilized form or in solution.

IPC Classes  ?

  • C12N 15/11 - DNA or RNA fragments; Modified forms thereof
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12Q 1/6848 - Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
  • C12N 9/58 - Proteinases derived from fungi

11.

Double-Stranded DNA Deaminases and Uses Thereof

      
Application Number 18323143
Status Pending
Filing Date 2023-05-24
First Publication Date 2023-11-09
Owner New England Biolabs, Inc. (USA)
Inventor
  • Sun, Zhiyi
  • Johnson, Sean R.
  • Yan, Bo
  • Chen, Lixin
  • Robb, G. Brett
  • Evans, Jr., Thomas C.
  • Vaisvila, Romualdas

Abstract

Provided herein, among other things, is a method for deaminating a double-stranded nucleic acid. In some embodiments, the method may comprise contacting a double-stranded DNA substrate that comprises cytosines and a double-stranded DNA deaminase having an amino acid sequence that is at least 80% identical to any of SEQ ID NOS: 21, 40, 47, 49, 50, 55, 58, 59, 62, 63, 65, 67, 70, 71, 76, 106, 107, 110, 112, 114, 117, 163 and/or 164 to produce a deamination product that comprises deaminated cytosines. Enzymes and kits for performing the method are also provided.

IPC Classes  ?

  • C12Q 1/6869 - Methods for sequencing
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 9/10 - Transferases (2.)
  • C12N 9/78 - Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5)

12.

LYOPRIME

      
Application Number 230217000
Status Pending
Filing Date 2023-11-06
Owner New England Biolabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

(1) Reagents for scientific research use; reagents for molecular biology and/or cell biology for scientific, research, laboratory or in vitro diagnostic use; reagents for diagnostic tests and/or diagnostic devices for scientific, research, laboratory or in vitro diagnostic use; reagents for genetic research, clinical or medical laboratory use; enzyme reagents for scientific, research, laboratory or in vitro diagnostic use; enzymes for scientific and/or research use; enzymes for molecular biology research and/or cell biology scientific and research applications.

13.

METHODS OF HIGHER FIDELITY RNA SYNTHESIS

      
Application Number US2023065496
Publication Number 2023/196950
Status In Force
Filing Date 2023-04-07
Publication Date 2023-10-12
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Roy, Bijoyita
  • Chen, Tien-Hao
  • Potapov, Vladimir
  • Ong, Jennifer
  • Dai, Nan

Abstract

NN 1in vitroin vitro.

IPC Classes  ?

  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides

14.

COMPOSITIONS AND ANALYSIS OF DEPHOSPHORYLATED OLIGORIBONUCLEOTIDES

      
Application Number US2023065602
Publication Number 2023/197015
Status In Force
Filing Date 2023-04-10
Publication Date 2023-10-12
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Correa, Ivan, R., Jr.
  • Wolf, Eric
  • Dai, Nan
  • Yigit, Erbay
  • Grünberg, Sebastian

Abstract

Homo sapiens, Escherichia coli, Aspergillus oryzae, Momordica charanlia. Pyrococcus furiosus, Cucumis sativusSus scrojdSus scrojd) or (ii) is a non-naturally occurring sequence; and/or an RNA end repair enzyme having an amino acid sequence that (i) corresponds to an amino acid sequence of a species other than the first species (e.g., a bacterial species or a bacteriophage species) or (ii) is a non-naturally occurring sequence.

IPC Classes  ?

15.

Compositions and Analysis of Dephosphorylated Oligoribonucleotides

      
Application Number 18298291
Status Pending
Filing Date 2023-04-10
First Publication Date 2023-09-14
Owner New England Biolabs, Inc. (USA)
Inventor
  • Correa, Jr., Ivan R.
  • Wolf, Eric
  • Dai, Nan
  • Yigit, Erbay
  • Grünberg, Sebastian

Abstract

The present disclosure relates, according to some embodiments, to compositions and analysis of RNA (e.g., dephosphorylated oligoribonucleotides) including, for example, natural and/or synthetic RNAs. A composition may comprise, for example, an endoribonuclease having an amino acid sequence that (i) corresponds to an amino acid sequence of a first species (e.g., Homo sapiens, Escherichia coli, Aspergillus oryzae, Momordica charantia, Pyrococcus furiosus, Cucumis sativus, and Sus scrofa) or (ii) is a non-naturally occurring sequence; and/or an RNA end repair enzyme having an amino acid sequence that (i) corresponds to an amino acid sequence of a species other than the first species (e.g., a bacterial species or a bacteriophage species) or (ii) is a non-naturally occurring sequence.

IPC Classes  ?

  • C12Q 1/6872 - Methods for sequencing involving mass spectrometry

16.

IMMOBILIZED ENZYME COMPOSITIONS AND METHODS

      
Application Number 18182122
Status Pending
Filing Date 2023-03-10
First Publication Date 2023-09-14
Owner New England Biolabs, Inc. (USA)
Inventor
  • Xu, Ming-Qun
  • García-Marquina, Guillermo
  • Chan, Siu-Hong
  • Correa, Jr., Ivan R.
  • Zhang, Aihua
  • Fang, Yi
  • Sproviero, Michael

Abstract

The present disclosure relates, according to some embodiments, to immobilized enzyme compositions and methods for cleaving polynucleotide molecules including, for example, double-stranded DNA. Immobilized enzymes may comprise, for example, an enzyme (e.g., a type IIS restriction endonuclease, an RNAP, a capping enzyme), a support (e.g., a magnetic bead), and optionally, a linker disposed between the enzyme and the support. In some embodiments, methods may include contacting an immobilized enzyme with a polynucleotide substrate to form reaction products, separating the immobilized enzyme from the reaction products, and optionally reusing the immobilized enzymes in one or more subsequent reactions. preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter-tagged fragments; and/or separating adapter-tagged fragments from the tailing enzyme and the ligase to produce separated adapter-tagged fragments and, optionally, separated tailing enzyme and/or separated ligase.

IPC Classes  ?

17.

TARGET ENRICHMENT

      
Application Number US2023063895
Publication Number 2023/172934
Status In Force
Filing Date 2023-03-08
Publication Date 2023-09-14
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Hendrickson, Cynthia
  • Patel, Kruti

Abstract

The present disclosure relates, according to some embodiments, to methods and compositions for preparing polynucleotide libraries enriched for a target sequence from source materials (e.g., samples comprising or constituting biological fluids, tissues, and/or specimens). Methods and compositions may provide efficient enrichment of the targeted polynucleotide. Enrichment may include increasing the relative abundance of the target from the source materials (where it may be present in low abundance) to the produced libraries (where it may be present in higher abundance). In some embodiments, methods include attaching (e.g., ligating, joining or otherwise fusing) an adapter to fragments of interest, nick translation, amplification (e.g., linear amplification), and target sequence selection using, for example, affinity tagging.

IPC Classes  ?

  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12Q 1/6816 - Hybridisation assays characterised by the detection means
  • C12Q 1/6844 - Nucleic acid amplification reactions
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12Q 1/6855 - Ligating adaptors

18.

IMMOBILIZED ENZYME COMPOSITIONS AND METHODS

      
Application Number US2023064156
Publication Number 2023/173098
Status In Force
Filing Date 2023-03-10
Publication Date 2023-09-14
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Xu, Ming-Qun
  • Garcia-Marquina, Guillermo
  • Chan, Siu-Hong
  • Correa, Ivan R., Jr.
  • Zhang, Aihua
  • Fang, Yi
  • Sproviero, Michael

Abstract

The present disclosure relates, according to some embodiments, to immobilized enzyme compositions and methods for cleaving polynucleotide molecules including, for example, double-stranded DNA. Immobilized enzymes may comprise, for example, an enzyme (e.g., a type IIS restriction endonuclease, an RNAP, a capping enzyme), a support (e.g., a magnetic bead), and optionally, a linker disposed between the enzyme and the support. In some embodiments, methods may include contacting an immobilized enzyme with a polynucleotide substrate to form reaction products, separating the immobilized enzyme from the reaction products, and optionally reusing the immobilized enzymes in one or more subsequent reactions, preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter-tagged fragments; and/or separating adapter-tagged fragments from the tailing enzyme and the ligase to produce separated adapter- tagged fragments and, optionally, separated tailing enzyme and/or separated ligase.

IPC Classes  ?

  • C12N 9/22 - Ribonucleases
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 11/06 - Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
  • C12N 11/14 - Enzymes or microbial cells immobilised on or in an inorganic carrier
  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides
  • C12N 11/02 - Enzymes or microbial cells immobilised on or in an organic carrier
  • C12N 9/00 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

19.

Double-Stranded DNA Deaminases

      
Application Number 18058115
Status Pending
Filing Date 2022-11-22
First Publication Date 2023-08-17
Owner New England Biolabs, Inc. (USA)
Inventor
  • Vaisvila, Romualdas
  • Johnson, Sean R.
  • Sun, Zhiyi
  • Evans, Jr., Thomas C.

Abstract

Provided herein, among other things, is a method for deaminating a double-stranded nucleic acid. In some embodiments, the method may comprise contacting a double-stranded DNA substrate that comprises cytosines and a double-stranded DNA deaminase having an amino acid sequence that is at least 80% identical to any of SEQ ID NOS: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 19, 24, 26, 27, 28, 33, 40, 49, 50, 63, 95, 96, 97, and/or 99 to produce a deamination product that comprises deaminated cytosines. Enzymes and kits for performing the method are also provided.

IPC Classes  ?

  • C12N 9/78 - Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

20.

Fragmentation of DNA

      
Application Number 18305745
Status Pending
Filing Date 2023-04-24
First Publication Date 2023-08-17
Owner New England Biolabs, Inc. (USA)
Inventor
  • Apone, Lynne
  • Sexton, Brittany S.
  • Heider, Margaret
  • Williams, Louise Js
  • Dimalanta, Eileen T.

Abstract

Provided herein is a polymerase-free enzyme mix (FRAG) for fragmenting double-stranded DNA. In some embodiments the enzyme mix may comprise a double-stranded DNA nickase and at least one of a DNA ligase capable of sealing a nick within a DNA, and a single-strand specific DNA nuclease. Methods for fragmenting double-stranded DNA are also provided.

IPC Classes  ?

21.

DOUBLE-STRANDED DNA DEAMINASES

      
Application Number US2022080345
Publication Number 2023/097226
Status In Force
Filing Date 2022-11-22
Publication Date 2023-06-01
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Vaisvila, Romualdas
  • Johnson, Sean, R.
  • Sun, Zhiyi
  • Evans, Thomas, C.

Abstract

Provided herein, among other things, is a method for deaminating a double-stranded nucleic acid. In some embodiments, the method may comprise contacting a double-stranded DNA substrate that comprises cytosines and a double-stranded DNA deaminase having an amino acid sequence that is at least 80% identical to any of SEQ. ID NOS: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 19, 24, 26, 27, 28, 33, 40, 49, 50, 63, 95, 96, 97, and/or 99 to produce a deamination product that comprises deaminated cytosines. Enzymes and kits for performing the method are also provided.

IPC Classes  ?

22.

Isolation of High Molecular Weight DNA Using Beads

      
Application Number 18155975
Status Pending
Filing Date 2023-01-18
First Publication Date 2023-05-18
Owner New England Biolabs, Inc. (USA)
Inventor
  • Koetsier, Paul A.
  • Taron, Barbara W.
  • Cantor, Eric J.

Abstract

Provided herein is a method for isolating high molecular weight (HMW) DNA using beads that are at least 200 μm in diameter that utilizes a device for retaining the beads and where the purified DNA eluant exits the device without shearing the HMW DNA. In some embodiments, the method comprises precipitating the DNA onto the beads, washing the beads in the device, and then eluting the DNA from the beads therein while substantially avoiding shear. Compositions and kits for practicing the method are also provided.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
  • B01L 9/06 - Test-tube stands; Test-tube holders

23.

MONARCH STABILYSE

      
Serial Number 97936536
Status Pending
Filing Date 2023-05-15
Owner New England Biolabs, Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments

Goods & Services

Biological and biochemical reagents for scientific or medical research use; Biological and biochemical kits comprising enzymes and reagents for scientific or medical research use; Diagnostic reagents for clinical or medical laboratory use; Chemical products for commercial and scientific purposes, namely, chemicals or biochemicals for the stabilization, preservation, purification, modification, and manipulation of nucleic acids for scientific purposes and for use in polymerase chain reaction; Reagents for scientific and research use, for the stabilization, preservation, purification, modification, and manipulation of biologic samples, namely, nucleic acids (RNA and DNA); Reagents for scientific and research use, for the inactivation of infectious agents, namely, virus, bacteria, and parasites; Reagents for sample preparation, stabilization, preservation, purification, lysis, modification, and manipulation of cells and tissues Reagents for medical use in the stabilization of biologic samples, namely, nucleic acids (RNA and DNA); Reagents for medical use for the inactivation of infectious agents, namely, virus, bacteria, and parasites; Reagents for medical use for preparation, stabilization, preservation, purification, lysis, modification, and manipulation of cells and tissues Devices, namely, sample collection tubes for scientific and research use for the inactivation of infectious agents, namely, virus, bacteria, and parasites; Devices, namely, sample collection tubes for scientific and research use for the preparation, stabilization, preservation, purification, lysis, modification, and manipulation of cells and tissues; Devices, namely, sample collection tubes for scientific and research use, for the stabilization, preservation, purification, modification, and manipulation of biologic samples, namely, nucleic acids (RNA and DNA)

24.

Rolling Circle Reverse Transcription of Circular RNA

      
Application Number 17820372
Status Pending
Filing Date 2022-08-17
First Publication Date 2023-05-11
Owner New England Biolabs, Inc. (USA)
Inventor
  • Guan, Shengxi
  • Maguire, Sean
  • Xu, Yan
  • Unlu, Irem

Abstract

Compositions, methods and kits are provided that enable the detection, analysis and/or sequencing of small or large target RNA molecules whether synthetic, purified or within a biological fluid, or in cell lysate that may contain non-target RNA and other contaminating molecules without the need for depletion or purification steps that diminish what might already be low concentrations of the target molecule. The methods, compositions and kits rely on the use of a Group II Intron reverse transcriptase (Intron-RT) that have strand displacing properties and can generate concatemers in cDNA by rolling circle transcription of circRNAs that may be naturally circular or circularized in vitro from linear RNA.

IPC Classes  ?

  • C12Q 1/6848 - Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction

25.

COMPOSITIONS AND METHODS FOR DETECTING PYROPHOSPHATE PRODUCTS OF ENZYME REACTIONS USING PYRIDYLAZOANILINE DYES

      
Application Number US2022076778
Publication Number 2023/076772
Status In Force
Filing Date 2022-09-21
Publication Date 2023-05-04
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Tanner, Nathan
  • Correa, Ivan, R., Jr.
  • Zhang, Yinhua
  • Alpaslan, Ece

Abstract

Provided herein is a composition comprising an enzyme that releases pyrophosphate from a substrate and a dye of Formula 1. A method for detecting pyrophosphate is also provided. A kit comprising a polymerase that releases pyrophosphate by hydrolysis of nucleoside triphosphates during nucleic acid replication, a divalent manganese salt, and the dye are also provided. The present composition, method and kits provide a way to detect and/or quantify substrates or products of enzyme reacted substrates associated with the release pyrophosphate (e.g., nucleic acid amplification reactions and other reactions that hydrolyze ATP) via a distinct color change without substantially affecting the sensitivity and/or specificity of the reaction.

IPC Classes  ?

  • G01N 33/52 - Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper
  • C12Q 1/48 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
  • C09B 29/036 - Monoazo dyes prepared by diazotising and coupling characterised by the diazo component from diazotised amines containing a heterocyclic ring the heterocyclic ring containing only nitrogen as hetero atoms
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • G01N 33/84 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

26.

Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA

      
Application Number 17907482
Status Pending
Filing Date 2021-06-08
First Publication Date 2023-04-20
Owner New England Biolabs, Inc. (USA)
Inventor
  • Pradhan, Sriharsa
  • Chin, Hang Gyeong
  • Feehery, George R.
  • Xu, Shuang-Yong
  • Udayakumaran Nair Sunitha Kumary, Vishnu
  • Beaulieu, Julie

Abstract

Compositions, methods and kits are provided for identifying the presence and location of a target in chromosomal DNA. A nicking endonuclease fused to a binding domain that binds to a constant region of an antibody (NEFP) is provided that may be used for binding to a target directly or via an antibody that binds to the target. The target may be a protein or structural feature of the DNA and its presence and location may correspond to a phenotype and/or pathology in a biopsy or other cell sample for diagnostic purposes. The background is reduced by the addition of a glycoaminoglycan (GAG) that reversibly inhibits binding of the NEFP to DNA. Nick translation in the presence of a strand displacing polymerase enables the incorporation of tagged nucleotides that (i) blocks re-nicking; (ii) facilitates immobilization of DNA fragments around the target for sequencing; and/or (iii) enables dye labelling of the chromosomal DNA within the cell nuclei for analysis by microscopy.

IPC Classes  ?

27.

Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA

      
Application Number 17933943
Status Pending
Filing Date 2022-09-21
First Publication Date 2023-03-23
Owner New England Biolabs, Inc. (USA)
Inventor
  • Pradhan, Sriharsa
  • Chin, Hang Gyeong
  • Feehery, George R.
  • Xu, Shuang-Yong
  • Udayakumaran Nair Sunitha Kumary, Vishnu
  • Beaulieu, Julie
  • Esteve, Pierre O.

Abstract

Compositions, methods and kits are provided for identifying the presence and location of a target in chromosomal DNA. A nicking endonuclease fused to a binding domain that binds to a constant region of an antibody (NEFP) is provided that may be used for binding to a target directly or via an antibody that binds to the target. The target may be a protein or structural feature of the DNA and its presence and location may correspond to a phenotype and/or pathology in a biopsy or other cell sample for diagnostic purposes. The background is reduced by the addition of a glycoaminoglycan (GAG) that reversibly inhibits binding of the NEFP to DNA. Nick translation in the presence of a strand displacing polymerase enables the incorporation of tagged nucleotides that (i) blocks re-nicking; (ii) facilitates immobilization of DNA fragments around the target for sequencing; and/or (iii) enables dye labelling of the chromosomal DNA within the cell nuclei for analysis by microscopy.

IPC Classes  ?

  • C12Q 1/6869 - Methods for sequencing
  • C07K 14/31 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
  • C12N 9/22 - Ribonucleases

28.

INDURO

      
Application Number 1716057
Status Registered
Filing Date 2023-02-01
Registration Date 2023-02-01
Owner New England Biolabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific and research use; enzymes for scientific and research use; reagents for scientific and research use in the field of molecular biology; enzymes for scientific and research use in the field of molecular biology; kits comprising enzymes for scientific and research applications in the field of molecular biology.

29.

Rapid diagnostic test for lamp

      
Application Number 17936084
Grant Number 11732315
Status In Force
Filing Date 2022-09-28
First Publication Date 2023-02-16
Grant Date 2023-08-22
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine B.
  • Strimpel, Harriet M.
  • Correa, Jr., Ivan R.
  • Carlow, Clotilde
  • Slayton, Esta
  • Evans, Jr., Thomas C.

Abstract

Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The compositions and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The compositions and methods are directed to labelled probes and their uses in Loop-Mediated Isothermal Amplification (LAMP) diagnostic tests to detect target DNA from the environment or from an individual and also to detect specific variants of the target DNA, both with similar sensitivity. The compositions and methods may use any single improvement or combination of improvements selected from thermolabile enzyme variants, poloxamers, various salts, indicators and one or more LAMP primer sets for detecting single and/or multiple targets, probes for detecting variants of the targets including SARS-CoV-2 variants and lateral flow devices.

IPC Classes  ?

  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
  • G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour

30.

INDURO

      
Application Number 224300300
Status Pending
Filing Date 2023-02-01
Owner New England Biolabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

(1) Reagents for scientific and research use; enzymes for scientific and research use; reagents for scientific and research use in the field of molecular biology; enzymes for scientific and research use in the field of molecular biology; kits comprising enzymes for scientific and research applications in the field of molecular biology.

31.

Methods for Labeling a Population of RNA Molecules

      
Application Number 17932136
Status Pending
Filing Date 2022-09-14
First Publication Date 2023-01-26
Owner New England Biolabs, Inc. (USA)
Inventor
  • Schildkraut, Ira
  • Ettwiller, Laurence
  • Correa, Jr., Ivan R.
  • Tzertzinis, George
  • Buswell, John
  • Wulf, Madalee G.

Abstract

A method of labeling, and optionally enriching, for a population of target RNA molecules in a mixture of RNAs is provided. In some embodiments, the method may comprise (a) adding a label to the 5′ end of 5′-diphosphorylated or 5′-triphosphorylated target RNA molecules in a sample by incubating the sample with labeled GTP and a capping enzyme; and (b) optionally enriching for target RNA comprising the affinity tag-labeled GMP using an affinity matrix that binds to the affinity tag. The label may be an oligonucleotide, which may further comprise an affinity group attached either internally or at 5′ or 3′ end of the oligonucleotide where the oligonucleotide label may be added directly, or indirectly via a reaction with a reactive group to the target RNA.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C07H 21/02 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

32.

NEBNEXT ULTRAEXPRESS

      
Serial Number 97767386
Status Pending
Filing Date 2023-01-25
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, molecular biology and cell biology applications comprising enzymes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for scientific and research use for genetic research, clinical or medical laboratory use; Kits for genetic research, nucleic acid sequencing, clinical or medical laboratory use comprising at least one of enzymes, buffers, cells and nucleic acids; Reagents for scientific and research use for use in sequencing nucleic acids; Kits for use in sequencing nucleic acids comprising at least one of enzymes, buffers, cells and nucleic acids

33.

High Throughput Reaction Assembly

      
Application Number 17936144
Status Pending
Filing Date 2022-09-28
First Publication Date 2023-01-19
Owner New England Biolabs, Inc. (USA)
Inventor
  • Ren, Guoping
  • Xu, Yan
  • Ma, Dong
  • Nichols, Nicole

Abstract

Provided herein is a reverse transcriptase mixture comprising a reverse transcriptase and a colored dye at a concentration in the range of 0.003%-1% (v/w). The colored dye may be visually observed during transfer of the mix from one vessel to another and addition of the mix to another mix can be confirmed by eye by observing the colored dye.

IPC Classes  ?

  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12Q 1/48 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12Q 1/6816 - Hybridisation assays characterised by the detection means
  • C12Q 1/6851 - Quantitative amplification
  • C12Q 1/686 - Polymerase chain reaction [PCR]
  • C12Q 1/6844 - Nucleic acid amplification reactions

34.

Vitro Cleavage of DNA Using Argonaute

      
Application Number 17930079
Status Pending
Filing Date 2022-09-07
First Publication Date 2023-01-05
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Hunt, Eric

Abstract

Methods, kits and compositions, in some embodiments, may include a thermostable DNA guided Argonaute protein for example TtAgo, a thermostable single-stranded DNA binding protein (SSB) for example, extreme thermostable single-stranded DNA binding protein (ET SSB), and, optionally, a strand-displacing polymerase. A SSB may allow (a) Argonaute/guide DNA complexes to substantially enhance cleavage efficiency of single- and double-stranded DNA substrates; (b) the use of longer guide DNAs (e.g., guide DNAs that are at least 24 nucleotides in length) and/or (c) increases in the sequence specificity of Argonaute-mediated binding and cleavage reactions.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C07K 14/195 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
  • C12N 9/22 - Ribonucleases
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 15/90 - Stable introduction of foreign DNA into chromosome
  • C12N 15/11 - DNA or RNA fragments; Modified forms thereof

35.

TARGET INITIATION AND AMPLIFICATION OF LONG DNA WITH NUCLEASE AND REPLISOME ENZYMES

      
Application Number US2022032777
Publication Number 2022/261281
Status In Force
Filing Date 2022-06-09
Publication Date 2022-12-15
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Tanner, Nathan
  • Nye, Dillon, B.

Abstract

in vitroin vitroin vitro linear amplification reaction enabling copying of at least 300 bases and as much as 50 kb of the target nucleic acid.

IPC Classes  ?

36.

AN ISOTHERMAL DIAGNOSTIC TEST THAT UTILIZES A CAS PROTEIN AND A POLYMERASE

      
Application Number US2022032814
Publication Number 2022/261308
Status In Force
Filing Date 2022-06-09
Publication Date 2022-12-15
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Tanner, Nathan
  • Fuchs, Ryan, T.
  • Curcuru, Jennifer, L.
  • Robb, Brett, G.

Abstract

Kits and methods are provided that utilize a mesophilic strand displacing polymerase selected from Bsu DNA polymerase (large fragment) and Klenow in Loop mediated amplification (LAMP) at temperatures in the range of 34°C-52°C. This contrasts with 60°C -65°C required for standard Bst polymerase dependent LAMP. The reduced temperature of the LAMP reaction enables the use of other proteins that are temperature sensitive in a one-step reaction. For example, a Cas protein such as Cas12a may be used with a target nucleic acid specific guide RNA and optionally a reporter oligonucleotide containing a quencher and a fluorophore or lateral flow reagents to determine the presence of pathogens in a sample.

IPC Classes  ?

37.

PROGRAMMABLE CLEAVAGE OF DOUBLE-STRANDED DNA

      
Application Number US2022031288
Publication Number 2022/256247
Status In Force
Filing Date 2022-05-27
Publication Date 2022-12-08
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Bitinatie, Jurate
  • Vaiskunaite, Rita
  • Potapov, Vladimir
  • Tanner, Nathan

Abstract

Clostridium butyricumClostridium butyricum) may be synchronized with DNA strand unwinding activity of a helicase (e.g., a nuclease deficient RecBexo- E.coli E.coli ) for a rapid and efficient cleavage of double-stranded DNA targets. Enzymatic properties of CbAgo and different aspects of ds DNA cleavage were thoroughly explored by adapting high-throughput capillary electrophoreses technique for monitoring CbAgo cleavage activity in concurrence with RecBexo-C. The present disclosure shows that in the presence of RecBexo-C., CbAgo can be programmed with guides to cleave any site of interest localized at up to 10 kb distance from the end of linear ds DNA at 37°C temperature. CbAgo /RecBexo-C. can be programmed to generate DNA fragments flanked with unique single- stranded extensions suitable for seamless ligation with compatible DNA fragments. The present disclosure relates further the compositions, methods, systems, and kits for PRC-free assembly of linear DNA molecules by using Cb Ago/RecBexo-C. programmable DNA endonuclease. The results presented here demonstrate that the combination of CbAgo and RecBexo-C. is currently an efficient mesophilic DNA-guided DNA-cleaving programmable endonuclease which can be used to prepare synthetic biology tools that require or benefit from sequence- specific nicking/cleavage of natural DNA at otherwise inaccessible locations.

IPC Classes  ?

  • C12N 15/72 - Expression systems using regulatory sequences derived from the lac-operon
  • C12N 9/22 - Ribonucleases
  • C12N 15/11 - DNA or RNA fragments; Modified forms thereof
  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides

38.

Programmable Cleavage of Double-Stranded DNA

      
Application Number 17335500
Status Pending
Filing Date 2021-06-01
First Publication Date 2022-12-01
Owner New England Biolabs, Inc. (USA)
Inventor
  • Bitinaite, Jurate
  • Vaiskunaite, Rita
  • Potapov, Vladimir
  • Tanner, Nathan

Abstract

The present disclosure relates, according to some embodiments, to compositions, methods, systems, and kits for programmable endonucleolytic cleavage of DNA (e.g., ds DNA). For example, the in vitro activity of an Argonaute (e.g., a mesophilic Argonaute CbAgo from Clostridium butyricum) may be synchronized with DNA strand unwinding activity of a helicase (e.g., a nuclease deficient RecBexo-C DNA helicase from E. coli) for a rapid and efficient cleavage of double-stranded DNA targets. Enzymatic properties of CbAgo and different aspects of ds DNA cleavage were thoroughly explored by adapting high-throughput capillary electrophoreses technique for monitoring CbAgo cleavage activity in concurrence with RecBexo-C. The present disclosure shows that in the presence of RecBexo-C, CbAgo can be programmed with guides to cleave any site of interest localized at up to 10 kb distance from the end of linear ds DNA at 37° C. temperature. CbAgo/RecBexo-C can be programmed to generate DNA fragments flanked with unique single-stranded extensions suitable for seamless ligation with compatible DNA fragments. The present disclosure relates further the compositions, methods, systems, and kits for PRC-free assembly of linear DNA molecules by using CbAgo/RecBexo-C programmable DNA endonuclease. The results presented here demonstrate that the combination of CbAgo and RecBexo-C is currently an efficient mesophilic DNA-guided DNA-cleaving programmable endonuclease which can be used to prepare synthetic biology tools that require or benefit from sequence-specific nicking/cleavage of natural DNA at otherwise inaccessible locations.

IPC Classes  ?

  • C12N 9/14 - Hydrolases (3.)
  • C07K 14/195 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
  • C12N 15/11 - DNA or RNA fragments; Modified forms thereof
  • C12N 15/90 - Stable introduction of foreign DNA into chromosome

39.

DNASE I VARIANTS, COMPOSITIONS, METHODS, AND KITS

      
Application Number US2021034605
Publication Number 2022/250676
Status In Force
Filing Date 2021-05-27
Publication Date 2022-12-01
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Crosby, Heidi
  • Ong, Jennifer
  • Luck, Ashley
  • Cantor, Eric, J.
  • Potapov, Vladimir

Abstract

The present disclosure relates, according to some embodiments, to systems, apparatus, compositions, methods, and workflows that include DNase I variants with desirable properties including, for example, salt tolerance. A DNase I variant, in some embodiments, may have an amino acid sequence that is at least 85% identical, at least 90% identical, at least 95% identical, and/or at least 98% identical to SEQ ID NO: 1 and may be identical to SEQ ID NO: 1 at one or more positions selected from the group of positions corresponding to L29, A35, D87, Q88, S94, P103, T108, P121, P132, A135, D145, E161, G172, P190, H208, and A224 of SEQ ID NO:1.

IPC Classes  ?

  • C12N 9/22 - Ribonucleases
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA

40.

HISCRIBE

      
Application Number 1699000
Status Registered
Filing Date 2022-11-03
Registration Date 2022-11-03
Owner New England Biolabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific and research use; enzymes for scientific and research use; kits comprising enzymes for scientific and research applications in the field of molecular biology or cell biology; reagents for scientific and research use in the field of molecular biology or cell biology applications; enzymes for scientific and research use in the field of molecular biology or cell biology applications; reagents for in vitro transcription for scientific and research use.

41.

Fragmentation of DNA

      
Application Number 17658485
Grant Number 11667968
Status In Force
Filing Date 2022-04-08
First Publication Date 2022-12-01
Grant Date 2023-06-06
Owner New England Biolabs, Inc. (USA)
Inventor
  • Apone, Lynne
  • Sexton, Brittany S.
  • Heider, Margaret
  • Williams, Louise J S
  • Dimalanta, Eileen T.

Abstract

Provided herein is a polymerase-free enzyme mix (FRAG) for fragmenting double-stranded DNA. In some embodiments the enzyme mix may comprise a double-stranded DNA nickase and at least one of a DNA ligase capable of sealing a nick within a DNA, and a single-strand specific DNA nuclease. Methods for fragmenting double-stranded DNA are also provided.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C40B 40/06 - Libraries containing nucleotides or polynucleotides, or derivatives thereof
  • C12Q 1/6869 - Methods for sequencing
  • C12Q 1/6855 - Ligating adaptors
  • C12Q 1/686 - Polymerase chain reaction [PCR]
  • C40B 20/04 - Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
  • C40B 50/06 - Biochemical methods, e.g. using enzymes or whole viable microorganisms

42.

DNase I Variants, Compositions, Methods, and Kits

      
Application Number 17332821
Status Pending
Filing Date 2021-05-27
First Publication Date 2022-12-01
Owner New England Biolabs, Inc. (USA)
Inventor
  • Crosby, Heidi
  • Ong, Jennifer
  • Luck, Ashley
  • Cantor, Eric J.
  • Potapov, Vladimir

Abstract

The present disclosure relates, according to some embodiments, to systems, apparatus, compositions, methods, and workflows that include DNase I variants with desirable properties including, for example, salt tolerance. A DNase I variant, in some embodiments, may have an amino acid sequence that is at least 85% identical, at least 90% identical, at least 95% identical, and/or at least 98% identical to SEQ ID NO:1 and may be identical to SEQ ID NO:1 at one or more positions selected from the group of positions corresponding to L29, A35, D87, Q88, S94, P103, T108, P121, P132, A135, D145, E161, G172, P190, H208, and A224 of SEQ ID NO:1.

IPC Classes  ?

  • C12N 9/22 - Ribonucleases
  • C07K 14/47 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from humans from vertebrates from mammals

43.

Compositions and methods for detecting pyrophosphate products of enzyme reactions using pyridylazoaniline dyes

      
Application Number 17661954
Grant Number 11512342
Status In Force
Filing Date 2022-05-04
First Publication Date 2022-11-29
Grant Date 2022-11-29
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Correa, Jr., Ivan R.
  • Zhang, Yinhua
  • Alpaslan, Ece

Abstract

Provided herein is a composition comprising an enzyme that releases pyrophosphate from a substrate and a dye of Formula 1. A method for detecting pyrophosphate is also provided. A kit comprising a polymerase that releases pyrophosphate by hydrolysis of nucleoside triphosphates during nucleic acid replication, a divalent manganese salt, and the dye are also provided. The present composition, method and kits provide a way to detect and/or quantify substrates or products of enzyme reacted substrates associated with the release pyrophosphate (e.g., nucleic acid amplification reactions and other reactions that hydrolyze ATP) via a distinct color change without substantially affecting the sensitivity and/or specificity of the reaction.

IPC Classes  ?

  • C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
  • C12Q 1/6816 - Hybridisation assays characterised by the detection means
  • C12Q 1/6844 - Nucleic acid amplification reactions
  • C12Q 1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

44.

HISCRIBE

      
Application Number 222554700
Status Pending
Filing Date 2022-11-03
Owner New England Biolabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

(1) Reagents for scientific and research use; enzymes for scientific and research use; kits comprising enzymes for scientific and research applications in the field of molecular biology or cell biology; reagents for scientific and research use in the field of molecular biology or cell biology applications; enzymes for scientific and research use in the field of molecular biology or cell biology applications; reagents for in vitro transcription for scientific and research use.

45.

Compositions and Methods Relating to Synthetic RNA Polynucleotides Created From Synthetic DNA Oligonucleotides

      
Application Number 17846620
Status Pending
Filing Date 2022-06-22
First Publication Date 2022-10-20
Owner New England Biolabs, Inc. (USA)
Inventor
  • Robb, G. B.
  • Meek, Isaac B.
  • Schwarz, Dianne S.
  • Schildkraut, Ezra

Abstract

Compositions and methods are provided for forming a single RNA polynucleotide from a plurality of DNA oligonucleotides in a single reaction chamber using combined reagents in a single step reaction. DNA polymerase, RNA polymerase and single stranded (ss) DNA oligonucleotides are combined where each DNA oligonucleotide has one or more sequence modules, wherein one sequence module in the first ss DNA oligonucleotide is complementary to a sequence module at the 3′ end of the second ss DNA oligonucleotide; and wherein a second module on the first ss DNA oligonucleotide is an RNA polymerase promoter sequence; and forming a single RNA polynucleotide, excluding the RNA promoter sequence, derived from the first and second DNA oligonucleotides

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides
  • C12N 9/22 - Ribonucleases
  • C12N 9/96 - Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
  • C12N 15/115 - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith

46.

Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides

      
Application Number 17825346
Status Pending
Filing Date 2022-05-26
First Publication Date 2022-09-29
Owner New England Biolabs, Inc. (USA)
Inventor Gardner, Andrew F.

Abstract

Provided herein, among other things, are various in vitro methods that involve cleaving dsDNA molecules that comprise a mismatched nucleotide using EndoMS. In some embodiments, the method may comprise ligating a T-tailed double-stranded adapter to A-tailed double-stranded fragments of nucleic acid to produce ligation products that comprise adapter-ligated fragments and double-stranded adapter dimers that comprise a T:T mismatch at the ligation junction and cleaving both strands of the adapter dimers using EndoMS.

IPC Classes  ?

  • C12Q 1/6855 - Ligating adaptors
  • C12N 9/22 - Ribonucleases
  • C12N 9/00 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
  • C12Q 1/6874 - Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation [SBH]

47.

Application of Immobilized Enzymes for Nanopore Library Construction

      
Application Number 17828574
Status Pending
Filing Date 2022-05-31
First Publication Date 2022-09-22
Owner New England Biolabs, Inc. (USA)
Inventor
  • Xu, Ming-Qun
  • Fang, Yi
  • Zhang, Aihua
  • Sun, Luo

Abstract

The present disclosure relates, according to some embodiments, to methods for preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter-tagged fragments; and/or separating adapter-tagged fragments from the tailing enzyme and the ligase to produce separated adapter-tagged fragments and, optionally, separated tailing enzyme and/or separated ligase. In some embodiments, a tailing enzyme and/or a ligase used in library preparation may be immobilized enzymes.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12Q 1/6869 - Methods for sequencing

48.

Use of Thermostable RNA Polymerases to Produce RNAs Having Reduced Immunogenicity

      
Application Number 17826946
Status Pending
Filing Date 2022-05-27
First Publication Date 2022-09-15
Owner New England Biolabs, Inc. (USA)
Inventor
  • Roy, Bijoyita
  • Robb, G. B.

Abstract

Provided herein, among other things, is a method for producing an RNA product that has reduced immunogenicity. In some embodiments, the method involves transcribing a template DNA with a thermostable RNA polymerase at a temperature of greater than 44° C.

IPC Classes  ?

  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides
  • A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

49.

Cleavage of Single Stranded DNA Having a Modified Nucleotide

      
Application Number 17637430
Status Pending
Filing Date 2020-08-21
First Publication Date 2022-09-08
Owner New England Biolabs, Inc. (USA)
Inventor
  • Gardner, Andrew F.
  • Zatopek, Kelly M.

Abstract

Methods are provided that, for example, include (a) combining ssDNA containing a modified nucleotide (e.g., a ssDNA with a modified nucleotide proximate to its 5′ end) with a DNA cleavage enzyme capable of cleaving the ssDNA at the modified nucleotide (e.g., to generate a first ssDNA fragment having a 3′OH and a second ssDNA fragment having the modified nucleotide); wherein the ratio of enzyme to DNA substrate is less than 1:1 molar ratio (m/m); and (b) cleaving at least 95% of the ssDNA at the modified nucleotide. In some embodiments, a method may comprise (a) combining (i) a ssDNA comprising a modified nucleotide (e.g., proximate to its 5′ end) with (ii) a DNA cleavage enzyme capable of cleaving the ssDNA at the modified nucleotide (e.g., to generate (after cleavage) a first ssDNA fragment having a 3′OH and a second ssDNA fragment comprising the modified nucleotide) wherein the ratio of enzyme to DNA substrate is less than 1:1 molar ratio and cleaving at least 95% of the ssDNA at the modified nucleotide. In some embodiments, methods provided herein may include (a) combining (i) a ssDNA (1) immobilized on a substrate and (2) comprising a modified nucleotide with (ii) a ssDNA cleaving enzyme capable of cleaving the ssDNA at the modified nucleotide (e.g., to generate (after cleavage) a first ssDNA fragment having a 3′OH and a second ssDNA fragment comprising the modified nucleotide) ; and (b) cleaving the immobilized ssDNA to release the second single stranded DNA fragment from the substrate. At least 95% (m/m) of an ssDNA comprising a modified nucleotide may be cleaved in less than 60 minutes.

IPC Classes  ?

  • C12N 9/22 - Ribonucleases
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
  • C07K 1/10 - General processes for the preparation of peptides using coupling agents

50.

Thermostable Variants of T7 RNA Polymerase

      
Application Number 17742033
Status Pending
Filing Date 2022-05-11
First Publication Date 2022-09-01
Owner New England Biolabs, Inc. (USA)
Inventor
  • Ong, Jennifer
  • Potapov, Vladimir
  • Hung, Kuo-Chan
  • Asahara, Haruichi
  • Chong, Shaorong
  • Tzertzinis, George

Abstract

A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.

IPC Classes  ?

  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12Q 1/6858 - Allele-specific amplification

51.

COMPOSITIONS AND METHODS FOR LABELING MODIFIED NUCLEOTIDES IN NUCLEIC ACIDS

      
Application Number US2022016743
Publication Number 2022/178093
Status In Force
Filing Date 2022-02-17
Publication Date 2022-08-25
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Ettwiller, Laurence
  • Weigele, Peter, R.
  • Yang, Weiwei
  • Lee, Yan-Jiun
  • Correa, Ivan, R.

Abstract

Compositions, methods and kits are provided that describe a novel enzyme family called here a hydroxymethylcytosine carbamoyltransferase that transfers a carbamoyl phosphate substrate onto a hydroxymethylcytosine nucleoside triphosphate or a hydroxymethylcytosine in a nucleic acid. The carbamoyl phosphate substrate may be tagged with a chemically reactive group and optionally a functional group. This enables multiple uses of this enzyme and substrate for detecting nucleic acids with modified nucleotides, enriching for such nucleic acids, sequencing nucleic acids containing modified nucleotides, and for synthesizing oligonucleotides with various labels for various molecular biology applications including stabilizing RNA.

IPC Classes  ?

  • C12Q 1/48 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12Q 1/6809 - Methods for determination or identification of nucleic acids involving differential detection

52.

FAUSTOVIRUS CAPPING ENZYME, MRNA CAPPING ENZYME COMPOSITIONS, METHODS AND KITS

      
Application Number US2021015320
Publication Number 2022/164428
Status In Force
Filing Date 2021-01-27
Publication Date 2022-08-04
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Chrispher, H.
  • Robb, G., Brett

Abstract

e.g.,e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

IPC Classes  ?

  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

53.

FCE mRNA capping enzyme compositions, methods and kits

      
Application Number 17377797
Grant Number 11725196
Status In Force
Filing Date 2021-07-16
First Publication Date 2022-07-28
Grant Date 2023-08-15
Owner New England Biolabs, Inc. (USA)
Inventor
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Christopher H.
  • Robb, G. B.

Abstract

The present disclosure relates to compositions, kits, and methods of making RNA vaccines having an appropriate cap structure. Systems, apparatus, compositions, and/or methods may include and/or use, in some embodiments, non-naturally occurring single-chain RNA capping enzymes. In some embodiments, an RNA capping enzyme may include an FCE variant having (a) an amino acid sequence at least 90% identical to positions 1 to 878 of SEQ ID NO: 1, and/or (b) one or more substitutions relative to SEQ ID NO: 1 at a position selected from positions corresponding to positions 215, 337, 572, 648, and 833 (e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

IPC Classes  ?

  • C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
  • A61K 39/245 - Herpetoviridae, e.g. herpes simplex virus
  • C12N 7/00 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
  • C12N 9/10 - Transferases (2.)
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • C07K 14/005 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses

54.

Methods and Enzymatic Compositions for Forming Libraries of Adapter Ligated Nucleic Acid Molecules

      
Application Number 17594534
Status Pending
Filing Date 2020-04-24
First Publication Date 2022-07-07
Owner New England Biolabs, Inc, (USA)
Inventor
  • Guan, Shengxi
  • Maguire, Sean

Abstract

Compositions and methods of use are provided that among other things, allow for efficient adapter ligation to small RNAs. Embodiments of the compositions include partially double stranded polynucleotides for use as 3′ adapters that contain a cleavable linker positioned between a single-stranded region and a double-stranded region. Upon ligating the 3′ adapters, the single-stranded region is released by cleaving the cleavable linker.

IPC Classes  ?

  • C12Q 1/6855 - Ligating adaptors
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA

55.

Rapid diagnostic test for LAMP

      
Application Number 17699950
Grant Number 11525166
Status In Force
Filing Date 2022-03-21
First Publication Date 2022-07-07
Grant Date 2022-12-13
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine B.
  • Strimpel, Harriet M.
  • Correa, Jr., Ivan R.
  • Carlow, Clotilde
  • Slayton, Esta

Abstract

Kits and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and one or more Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets and variants of the targets including SARS-CoV-2 targets and variants thereof in a single reaction. The kits and methods permit detection of the target nucleic with similar sensitivity regardless of the presence of undefined mutations that may enhance the virulence of cells or viruses containing the undefined mutations.

IPC Classes  ?

  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
  • G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour

56.

AUTHENTICASE

      
Serial Number 97489697
Status Registered
Filing Date 2022-07-05
Registration Date 2023-12-19
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits comprised of enzymes for molecular biology and cell biology applications; Reagents for scientific and research use for molecular biology and cell biology applications; Enzymes for scientific and research use for molecular biology and cell biology applications; Reagents for scientific and research use for use in sequencing applications; Enzymes for scientific and research use for use in sequencing applications; Kits comprised of reagents and enzymes for use in sequencing applications for scientific use; Diagnostic reagents for clinical or medical laboratory use; Biological and biochemical reagents and kits comprised of biological and biochemical reagents for scientific or medical research use

57.

Chemical Capping for Template Switching

      
Application Number 17610081
Status Pending
Filing Date 2020-05-06
First Publication Date 2022-06-23
Owner New England Biolabs, Inc. (USA)
Inventor
  • Correa, Jr., Ivan R.
  • Guan, Shengxi
  • Wulf, Madalee G.
  • Dai, Nan
  • Maguire, Sean

Abstract

Provided herein is a method for chemically capping polynucleotides having a 5′ monophosphate. In some embodiments the method may comprise: combining an activated nucleoside 5′ mono- or poly-phosphate with a population of polynucleotides that comprises polynucleotides having a 5′ monophosphate, to produce a reaction mix; and incubating the reaction mix to produce reaction products that comprise a polynucleotide and a 5′ nucleoside cap, linked by a 5′ to 5′ polyphosphate linkage. The chemical capping method described herein can be incorporated into a variety of cDNA synthesis methods.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

58.

IN VITRO ASSEMBLY OF POLYNUCLEOTIDES

      
Application Number US2021010063
Publication Number 2022/132198
Status In Force
Filing Date 2021-12-15
Publication Date 2022-06-23
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Lohman, Gregory
  • Potapov, Vladimir
  • Pryor, John, M.
  • Kucera, Rebecca
  • Bilotti, Katharina
  • Morgan, Richard, D.

Abstract

Ordered assembly of large numbers of fragments into a single large DN A have been improved in both frequency and fidelity of the assembled product. This has been achieved by novel compositions and methods that are utilized in a computer system that integrates comprehensive ligation data from multiple sources to provide optimized synthetic overhangs or overhangs from restriction endonuclease cleavage on DIMA fragments for assembly by ligation. Intragenic cut sites are avoided by the use of a novel restriction endonuclease which recognizes 7 nucleotides (bases) and cuts DNA to create 4-base overhangs with the help of a synthetic activator oligonucleotide. Variations in ligation preferences by different ligases provide extra precision in assembly reactions. The use of the improved methods are exemplified by the successful assembly from 52 fragments of a viral genome and also a 52 fragment ordered assembly of a bacteria operon.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12N 15/11 - DNA or RNA fragments; Modified forms thereof
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • G16B 25/20 - Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation

59.

Compositions and Methods for Improved In Vitro Assembly of Polynucleotides

      
Application Number 17644987
Status Pending
Filing Date 2021-12-17
First Publication Date 2022-06-09
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Lohman, Gregory
  • Potapov, Vladimir
  • Pryor, John M.
  • Kucera, Rebecca
  • Bilotti, Katharina
  • Morgan, Richard D.

Abstract

Ordered assembly of large numbers of fragments into a single large DNA have been improved in both frequency and fidelity of the assembled product. This has been achieved by novel compositions and methods that are utilized in a computer system that integrates comprehensive ligation data from multiple sources to provide optimized synthetic overhangs or overhangs from restriction endonuclease cleavage on DNA fragments for assembly by ligation. Intragenic cut sites are avoided by the use of a novel restriction endonuclease which recognizes 7 nucleotides (bases) and cuts DNA to create 4-base overhangs with the help of a synthetic activator oligonucleotide. Variations in ligation preferences by different ligases provide extra precision in assembly reactions. The use of the improved methods are exemplified by the successful assembly from 52 fragments of a viral genome and also a 52 fragment ordered assembly of a bacteria operon.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides
  • C12Q 1/6855 - Ligating adaptors

60.

Ordered Assembly of Multiple DNA Fragments

      
Application Number 17644516
Status Pending
Filing Date 2021-12-15
First Publication Date 2022-03-31
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Lohman, Gregory
  • Pryor, John M.
  • Kucera, Rebecca
  • Potapov, Vladimir
  • Bilotti, Katharina
  • Morgan, Richard D.

Abstract

A composition and its uses and additionally a kit are provided. The composition is a synthetic self-complementary oligonucleotide that has a double-stranded region and a loop, wherein the double-stranded region contains a binding sequence for PaqCl. Additionally, the oligonucleotide includes unligatable 3′ and 5′ ends that cannot be cleaved by PaqCl. This oligonucleotide composition has been combined with PaqCl or a variant of PaqCl Type IIS restriction endonuclease in a reaction mixture, where the reaction mixture includes PaqCl or variant that can further be combined with a ligase and optionally a deadenylase, crowding molecule such as PEG and/or a repair enzyme such as Endo MS. The kit includes the oligonucleotide and Type IIS restriction endonuclease in the same or different containers.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12Q 1/6869 - Methods for sequencing

61.

Application of immobilized enzymes for nanopore library construction

      
Application Number 17018862
Grant Number 11377654
Status In Force
Filing Date 2020-09-11
First Publication Date 2022-03-24
Grant Date 2022-07-05
Owner New England Biolabs, Inc. (USA)
Inventor
  • Xu, Ming-Qun
  • Fang, Yi
  • Zhang, Aihua
  • Sun, Luo

Abstract

The present disclosure relates, according to some embodiments, to methods for preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter-tagged fragments; and/or separating adapter-tagged fragments from the tailing enzyme and the ligase to produce separated adapter-tagged fragments and, optionally, separated tailing enzyme and/or separated ligase. In some embodiments, a tailing enzyme and/or a ligase used in library preparation may be immobilized enzymes.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12Q 1/6869 - Methods for sequencing

62.

NEBINSPIRED

      
Serial Number 97316669
Status Registered
Filing Date 2022-03-17
Registration Date 2023-04-04
Owner New England Biolabs, Inc. ()
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

On-line journals, namely, blogs featuring topics on science, art, lab tips, environmental sustainability, career advice and social responsibility; Providing a website featuring blogs and non-downloadable publications in the nature of articles in the field(s) of life sciences

63.

APPLICATION OF IMMOBILIZED ENZYMES FOR NANOPORE LIBRARY CONSTRUCTION

      
Application Number US2020050520
Publication Number 2022/055500
Status In Force
Filing Date 2020-09-11
Publication Date 2022-03-17
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Xu, Ming-Qun
  • Fang, Yi
  • Zhang, Aihua
  • Sun, Luo

Abstract

The present disclosure relates, according to some embodiments, to methods for preparing a library for sequencing. For example, a method may comprise (a) in a coupled reaction, (i) contacting a population of nucleic acid fragments with a tailing enzyme to produce tailed fragments, and (ii) ligating to the tailed fragments a sequencing adapter with a ligase to produce adapter- tagged fragments; and/or separating adapter- tagged fragments from the tailing enzyme and the ligase to produce separated adapter-tagged fragments and, optionally, separated tailing enzyme and/or separated ligase. In some embodiments, a tailing enzyme and/or a ligase used in library preparation may be immobilized enzymes.

IPC Classes  ?

  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12Q 1/6869 - Methods for sequencing

64.

Analysis of chromatin using a nicking enzyme

      
Application Number 17454082
Grant Number 11840741
Status In Force
Filing Date 2021-11-09
First Publication Date 2022-02-24
Grant Date 2023-12-12
Owner New England Biolabs, Inc. (USA)
Inventor
  • Ponnaluri, Chaithanya
  • Chin, Hang-Gyeong
  • Esteve, Pierre O.
  • Pradhan, Sriharsa

Abstract

Provided herein, among other things, are various compositions and methods for analyzing chromatin. In some embodiments, the composition may comprise a mixture of a nicking enzyme, four dNTPs, at least one labeled dNTP and, optionally, a polymerase. In some embodiments, this method may comprise: obtaining a sample comprising chromatin, reacting the sample with the composition to selectively label the open chromatin in the sample, and analyzing the labeled sample.

IPC Classes  ?

  • C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
  • C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12Q 1/6841 - In situ hybridisation
  • C12Q 1/6869 - Methods for sequencing
  • C12Q 1/6827 - Hybridisation assays for detection of mutation or polymorphism

65.

A RAPID DIAGNOSTIC TEST FOR LAMP

      
Application Number US2021046730
Publication Number 2022/040443
Status In Force
Filing Date 2021-08-19
Publication Date 2022-02-24
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine, B.
  • Strimpel, Harriet, M.
  • Correa, Ivan, R., Jr.
  • Carlow, Clotilde
  • Slayton, Esta

Abstract

Kits and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and one or more Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets and variants of the targets including SARS-CoV-2 targets and variants thereof in a single reaction. The kits and methods permit detection of the target nucleic with similar sensitivity regardless of the presence of undefined mutations that may enhance the virulence of cells or viruses containing the undefined mutations.

IPC Classes  ?

  • C12Q 1/6844 - Nucleic acid amplification reactions
  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

66.

NEBNEXT ULTRASHEAR

      
Serial Number 97278155
Status Registered
Filing Date 2022-02-22
Registration Date 2023-12-19
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, molecular biology and cell biology applications comprising enzymes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for scientific and research use for genetic research, clinical or medical laboratory use; Kits for genetic research, nucleic acid sequencing, clinical or medical laboratory use comprising at least one of enzymes, buffers, cells and nucleic acids; Reagents for scientific and research use for use in sequencing nucleic acids; Kits for use in sequencing nucleic acids comprising at least one of enzymes, buffers, cells and nucleic acids

67.

NEBRIDGE LIGASE FIDELITY VIEWER

      
Serial Number 97242105
Status Registered
Filing Date 2022-01-27
Registration Date 2023-07-11
Owner New England Biolabs, Inc. ()
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Providing a website featuring on-line non-downloadable software tools for use in molecular biology and diagnostic experimental design, namely, software for designing, analyzing, and visualizing polynucleotide assembly components, polynucleotide assemblies, and assembly ligation fidelity

68.

NEBRIDGE GETSET

      
Serial Number 97242111
Status Registered
Filing Date 2022-01-27
Registration Date 2023-04-18
Owner New England Biolabs, Inc. ()
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Providing a website featuring on-line non-downloadable software tools for use in molecular biology and diagnostic experimental design, namely, software for designing, analyzing, and visualizing polynucleotide assembly components, polynucleotide assemblies, and assembly ligation fidelity

69.

NEBRIDGE

      
Serial Number 97242088
Status Registered
Filing Date 2022-01-27
Registration Date 2023-07-11
Owner New England Biolabs, Inc. ()
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Providing a website featuring on-line non-downloadable software tools for use in molecular biology and diagnostic experimental design, namely, software for designing, analyzing, and visualizing polynucleotide assembly components, polynucleotide assemblies, and assembly ligation fidelity

70.

NEBRIDGE SPLITSET

      
Serial Number 97242115
Status Registered
Filing Date 2022-01-27
Registration Date 2023-04-18
Owner New England Biolabs, Inc. ()
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Providing a website featuring on-line non-downloadable software tools for use in molecular biology and diagnostic experimental design, namely, software for designing, analyzing, and visualizing polynucleotide assembly components, polynucleotide assemblies, and assembly ligation fidelity

71.

HISCRIBE HI-T7

      
Serial Number 97219453
Status Registered
Filing Date 2022-01-14
Registration Date 2024-04-02
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific and research use; Enzymes for scientific and research use; Kits comprising enzymes for scientific and research applications in the field of molecular biology or cell biology; Reagents for scientific and research use in the field of molecular biology or cell biology applications; Enzymes for scientific and research use in the field of molecular biology or cell biology applications; Reagents for in vitro transcription for scientific and research use

72.

Rapid diagnostic test for LAMP

      
Application Number 17406959
Grant Number 11345970
Status In Force
Filing Date 2021-08-19
First Publication Date 2021-12-30
Grant Date 2022-05-31
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine B.
  • Strimpel, Harriet M.
  • Correa, Jr., Ivan R.
  • Carlow, Clotilde
  • Slayton, Esta

Abstract

Kits and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and one or more Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets and variants of the targets including SARS-CoV-2 targets and variants thereof in a single reaction. The kits and methods permit detection of the target nucleic with similar sensitivity regardless of the presence of undefined mutations that may enhance the virulence of cells or viruses containing the undefined mutations.

IPC Classes  ?

  • G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

73.

Vaccinia capping enzyme compositions and methods

      
Application Number 17348127
Grant Number 11788074
Status In Force
Filing Date 2021-06-15
First Publication Date 2021-12-23
Grant Date 2023-10-17
Owner New England Biolabs, Inc. (USA)
Inventor
  • Vainauskas, Saulius
  • Chan, Siu-Hong
  • Taron, Christopher H.

Abstract

The present disclosure relates, according to some embodiments, to compositions, methods, and/or kits for producing vaccinia capping enzyme. For example, active, heterodimers of vaccinia capping enzyme may be produced as fusions comprising D1 and D12 subunits. Vaccinia capping enzyme fusion proteins may further comprise a linker.

IPC Classes  ?

  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C12R 1/84 - Pichia

74.

Compositions and methods for detecting molecular targets on chromosomal DNA

      
Application Number 17342216
Grant Number 11492667
Status In Force
Filing Date 2021-06-08
First Publication Date 2021-12-16
Grant Date 2022-11-08
Owner New England Biolabs, Inc. (USA)
Inventor
  • Pradhan, Sriharsa
  • Chin, Hang Gyeong
  • Feehery, George R.
  • Xu, Shuang-Yong
  • Udayakumaran Nair Sunitha Kumary, Vishnu
  • Beaulieu, Julie
  • Esteve, Pierre O.

Abstract

Compositions, methods and kits are provided for identifying the presence and location of a target in chromosomal DNA. A nicking endonuclease fused to a binding domain that binds to a constant region of an antibody (NEFP) is provided that may be used for binding to a target directly or via an antibody that binds to the target. The target may be a protein or structural feature of the DNA and its presence and location may correspond to a phenotype and/or pathology in a biopsy or other cell sample for diagnostic purposes. The background is reduced by the addition of a glycoaminoglycan (GAG) that reversibly inhibits binding of the NEFP to DNA. Nick translation in the presence of a strand displacing polymerase enables the incorporation of tagged nucleotides that (i) blocks re-nicking; (ii) facilitates immobilization of DNA fragments around the target for sequencing; and/or (iii) enables dye labelling of the chromosomal DNA within the cell nuclei for analysis by microscopy.

IPC Classes  ?

  • C12Q 1/6869 - Methods for sequencing
  • C07K 14/31 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
  • C12N 9/22 - Ribonucleases

75.

COMPOSITIONS AND METHODS FOR DETECTING MOLECULAR TARGETS ON CHROMOSOMAL DNA

      
Application Number US2021036414
Publication Number 2021/252498
Status In Force
Filing Date 2021-06-08
Publication Date 2021-12-16
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Pradhan, Sriharsa
  • Chin, Hang Gyeong
  • Feehery, George R.
  • Xu, Shuang-Yong
  • Udayakumaran Nair Sunitha Kumary, Vishnu
  • Beaulieu, Julie
  • Esteve, Pierre Olivier

Abstract

Compositions, methods and kits are provided for identifying the presence and location of a target in chromosomal DNA. A nicking endonuclease fused to a binding domain that binds to a constant region of an antibody (NEFP) is provided that may be used for binding to a target directly or via an antibody that binds to the target. The target may be a protein or structural feature of the DNA and its presence and location may correspond to a phenotype and/or pathology in a biopsy or other cell sample for diagnostic purposes. The background is reduced by the addition of a glycoaminoglycan (GAG) that reversibly inhibits binding of the NEFP to DNA. Nick translation in the presence of a strand displacing polymerase enables the incorporation of tagged nucleotides that (i) blocks re-nicking; (ii) facilitates immobilization of DNA fragments around the target for sequencing; and/or (iii) enables dye labelling of the chromosomal DNA within the cell nuclei for analysis by microscopy.

IPC Classes  ?

76.

Compositions and Methods for Analyzing Modified Nucleotides

      
Application Number 17445286
Status Pending
Filing Date 2021-08-17
First Publication Date 2021-12-16
Owner New England Biolabs, Inc. (USA)
Inventor
  • Vaisvila, Romualdas
  • Sun, Zhiyi
  • Guan, Shengxi
  • Saleh, Lana
  • Ettwiller, Laurence
  • Davis, Theodore B.

Abstract

A method for identifying any of the presence, location and phasing of modified cytosines (C) in long stretches of nucleic acids is provided. In some embodiments, the method may comprise (a) reacting a first portion of a nucleic acid sample containing at least one C and/or at least one modified C with a DNA glucosyltransferase and a cytidine deaminase to produce a first product and/or reacting a second portion of the sample with a dioxygenase, optionally a DNA glucosyltransferase and a cytidine deaminase to produce a second product and; (b) comparing the sequences from the first and optionally the second product obtained in (a), or amplification products thereof, with each other and/or an untreated reference sequence to determine which Cs in the initial nucleic acid fragment are modified. A modified TET methylcytosine dioxygenase with improved efficiency compared to unmodified TET2 at converting methylcytosine to carboxymethylcytosine is also provided.

IPC Classes  ?

  • C12Q 1/6858 - Allele-specific amplification
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12Q 1/6827 - Hybridisation assays for detection of mutation or polymorphism
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12Q 1/6869 - Methods for sequencing
  • C12Q 1/6872 - Methods for sequencing involving mass spectrometry

77.

Improved Ordered Assembly of Multiple DNA Fragments

      
Application Number 17286066
Status Pending
Filing Date 2019-10-17
First Publication Date 2021-12-09
Owner New England Biolabs, Inc. (USA)
Inventor
  • Lohman, Gregory
  • Potapov, Vladimir
  • Pryor, John M.
  • Kucera, Rebecca

Abstract

Methods and compositions are provided for optimizing ordered assembly of a plurality of polynucleotide fragments. The optimization involves providing sets of overhang sequences with preferred experimental conditions for high fidelity ordered assembly of polynucleotide fragments by ligation under selected experimental conditions. The methods and compositions provide the use of a computer system with inputs having a plurality of menus and outputs that include a variety of media interfaces. The computer system has access to a ligation frequency database to provide sets of overhang sequences for efficient joining of multiple fragments into the target nucleic acid. In-puts include one or more of the following: numbers and sizes of fragments, optionally a desired target polynucleotide sequence from a database, in which case one output are the recommended polynucleotide fragments for ordered assembly, and selected experimental conditions selected from any or all of ligation protocols and ligation temperature with reaction times, salt concentration in the ligation buffer, choice of ligase and restriction endonuclease and the use of DNA repair enzymes.

IPC Classes  ?

  • G16B 30/20 - Sequence assembly
  • C12N 15/66 - General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
  • G16B 50/30 - Data warehousing; Computing architectures

78.

BST 2.0 WARMSTART

      
Serial Number 97159916
Status Pending
Filing Date 2021-12-07
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Enzymes for scientific and research use in the field of molecular biology and cell biology applications

79.

BST 2.0

      
Serial Number 97063615
Status Pending
Filing Date 2021-10-07
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Enzymes for scientific and research use in the field of molecular biology and cell biology applications

80.

BST 2.0

      
Application Number 018572500
Status Registered
Filing Date 2021-10-06
Registration Date 2022-02-22
Owner New England BioLabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Enzymes for scientific and research use in the field of molecular biology and cell biology applications.

81.

Method for fragmenting DNA by nick translation

      
Application Number 17243707
Grant Number 11802304
Status In Force
Filing Date 2021-04-29
First Publication Date 2021-09-23
Grant Date 2023-10-31
Owner New England Biolabs, Inc. (USA)
Inventor
  • Guan, Chudi
  • Yan, Bo

Abstract

Providing herein, among other things, are kits, compositions and methods that relate to DNA fragmentation. An embodiment of a composition provides combining: one or more enzymes capable of nick translating activity, a dNTP mix comprising at least one dNTP having a modified base, and at least one modification-sensitive nicking endonuclease that is prevented from nicking DNA if its recognition site contains the modified base. When the composition is added to a sample comprising a double-stranded DNA template that comprises recognition sites for the modification-sensitive nicking endonuclease, a reaction mix was produced which could be incubated for any time period in excess of about 5 minutes to produce fragments of a desired size of the double-stranded DNA template. In this method, the fragments produced include the modified base and, as such, are not re-nicked by the nicking endonuclease.

IPC Classes  ?

  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12Q 1/6855 - Ligating adaptors
  • C12N 15/66 - General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
  • C12N 9/22 - Ribonucleases

82.

Rapid diagnostic test using colorimetric lamp

      
Application Number 17178395
Grant Number 11492673
Status In Force
Filing Date 2021-02-18
First Publication Date 2021-09-16
Grant Date 2022-11-08
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Nichols, Nicole

Abstract

Kits and methods are provided for performing multiplex LAMP reactions. These kits and methods are directed to specific and sensitive methods of target nucleic acid detection and more specifically pathogen diagnostics such as detection of Coronavirus. The kits and methods utilize a plurality of sets of oligonucleotide primers for targeting the viral nucleic acid target.

IPC Classes  ?

  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
  • G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
  • C12Q 1/6844 - Nucleic acid amplification reactions

83.

Rapid diagnostic test using colorimetric LAMP

      
Application Number 17221451
Grant Number 11155887
Status In Force
Filing Date 2021-04-02
First Publication Date 2021-09-16
Grant Date 2021-10-26
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Nichols, Nicole

Abstract

Kits and methods are provided for performing multiplex Loop-Mediated Isothermal Amplification (LAMP) reactions. These kits and methods are directed to specific and sensitive methods of target nucleic acid detection and more specifically pathogen diagnostics such as detection of Coronavirus. The kits and methods utilize a plurality of sets of oligonucleotide primers for targeting the viral nucleic acid target.

IPC Classes  ?

  • G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

84.

A RAPID DIAGNOSTIC TEST FOR LAMP

      
Application Number US2021022160
Publication Number 2021/183921
Status In Force
Filing Date 2021-03-12
Publication Date 2021-09-16
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Hunt, Eric
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Barry, Andrew
  • Nichols, Nicole
  • Poole, Catherine, B.
  • Strimpel, Harriet, M.
  • Correa, Ivan, R., Jr.

Abstract

Kits and Methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and multiple Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets in a single reaction.

IPC Classes  ?

  • C12Q 1/6844 - Nucleic acid amplification reactions
  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

85.

LYOPRIME LUNA

      
Serial Number 97024139
Status Registered
Filing Date 2021-09-13
Registration Date 2023-04-11
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific research use; reagents for molecular biology and/or cell biology for scientific, research, laboratory or in vitro diagnostic use; reagents for diagnostic tests and/or diagnostic devices for scientific, research, laboratory or in vitro diagnostic use; reagents for genetic research, clinical or medical laboratory use; enzyme reagents for scientific, research, laboratory or in vitro diagnostic use; enzymes for scientific and/or research use; enzymes for molecular biology research and/or cell biology scientific and research applications

86.

FCE mRNA capping enzyme compositions, methods and kits

      
Application Number 17246454
Grant Number 11098295
Status In Force
Filing Date 2021-04-30
First Publication Date 2021-08-24
Grant Date 2021-08-24
Owner New England Biolabs, Inc. (USA)
Inventor
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Christopher H.
  • Robb, G. B.

Abstract

The present disclosure relates to compositions, kits, and methods of making RNA vaccines having an appropriate cap structure. Systems, apparatus, compositions, and/or methods may include and/or use, in some embodiments, non-naturally occurring single-chain RNA capping enzymes. In some embodiments, an RNA capping enzyme may include an FCE variant having (a) an amino acid sequence at least 90% identical to positions 1 to 878 of SEQ ID NO: 1, and/or (b) one or more substitutions relative to SEQ ID NO: 1 at a position selected from positions corresponding to positions 215, 337, 572, 648, and 833 (e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

IPC Classes  ?

  • C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 7/00 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
  • C12N 9/10 - Transferases (2.)
  • A61K 39/245 - Herpetoviridae, e.g. herpes simplex virus
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies

87.

VARIANT FAMILY D DNA POLYMERASES

      
Application Number US2021017956
Publication Number 2021/163561
Status In Force
Filing Date 2021-02-12
Publication Date 2021-08-19
Owner NEW ENGLAND BIOLABS, INC. (USA)
Inventor
  • Gardner, Andrew, F.
  • Zatopek, Kelly, M.
  • Evans, Thomas, C.
  • Alpaslan, Ece

Abstract

The present disclosure relates to polymerases (e.g., variants of Family D DNA polymerases) for polynucleotide synthesis, polynucleotide amplification, polynucleotide sequencing, cloning a polynucleotide, or combinations thereof. Variant Family D polymerases have one or more substitutions relative to wild type Family D polymerases (e.g., substitutions impacting substrate selectivity) and may incorporate ribonucleotides and/or modified nucleotides into synthesized or extended strands.

IPC Classes  ?

  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

88.

VARIANT FAMILY D DNA POLYMERASES

      
Application Number US2021017954
Publication Number 2021/163559
Status In Force
Filing Date 2021-02-12
Publication Date 2021-08-19
Owner
  • NEW ENGLAND BIOLABS, INC. (USA)
  • INSTITUT PASTEUR (France)
Inventor
  • Gardner, Andrew, F.
  • Zatopek, Kelly, M.
  • Evans, Thomas, C.
  • Alpaslan, Ece
  • Sauguet, Ludovic

Abstract

The present disclosure relates to polymerases (e.g., variants of Family D DNA polymerases) for polynucleotide synthesis, polynucleotide amplification, polynucleotide sequencing, cloning a polynucleotide, or combinations thereof. For example, a variant Family D polymerase may have an amino acid sequence that (a) is at least 99%, identical to SEQ ID NO:1 and (b) has a substitution at a position selected from positions corresponding to positions 106-161, 243-267, 326-330, 361-365, 385-397, 441-451, 657-667, 822-829, 919-928, and 940-962, 981-997 of SEQ ID NO:1.

IPC Classes  ?

  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

89.

HISCRIBE

      
Serial Number 90885013
Status Registered
Filing Date 2021-08-16
Registration Date 2022-09-13
Owner New England Biolabs, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Reagents for scientific and research use; enzymes for scientific and research use; kits comprising enzymes for scientific and research applications in the field of molecular biology or cell biology; reagents for scientific and research use in the field of molecular biology or cell biology applications; enzymes for scientific and research use in the field of molecular biology or cell biology applications; reagents for in vitro transcription for scientific and research use

90.

NEAT-SEQ

      
Serial Number 90879289
Status Pending
Filing Date 2021-08-12
Owner New England Biolabs, Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 09 - Scientific and electric apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Reagents and reagent kits comprising enzymes, labels, buffers, DNA binding molecules or antibodies for the purpose of analyzing chromosomal DNA, DNA structure, nucleotide sequence variants or nucleotide modifications in or from in vitro or in the biological compartments or chromosomal DNA that are normal or abnormal, in the fields of scientific, diagnostic and clinical research Computer hardware and recorded computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; scientific apparatus and instruments, namely, nucleic acid sequencers for laboratory use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics Custom design and/or data analysis of assays for scientific and research purposes for location of DNA binding proteins in in vitro samples, biological compartments or on chromosomal DNA; Custom design and/or data analysis of assays for identifying nucleotide variants and modifications in vitro or in biological compartments or chromosomal DNA; Custom design and/or data analysis of assays for determining DNA structure; Providing online, non-downloadable software tools for sequencing, mapping, recording or archiving located nucleic sequences associated with DNA binding proteins, DNA structure, nucleotide variants or modifications from in vitro samples, biological compartments or on chromosomal DNA

91.

High Fidelity Restriction Endonucleases

      
Application Number 17226693
Status Pending
Filing Date 2021-04-09
First Publication Date 2021-08-05
Owner New England Biolabs, Inc. (USA)
Inventor
  • Zhu, Zhenyu
  • Quimby, Aine
  • Guan, Shengxi
  • Sun, Dapeng
  • Huang, Yishu
  • Lai, Xuhui
  • Chan, Siu-Hong
  • Li, Xianghui
  • Xu, Shuang-Yong
  • Zhang, Chunhua

Abstract

Methods and compositions are provided for engineering mutant enzymes with reduced star activity where the mutant enzymes have a fidelity index (FI) in a specified buffer that is greater than the FI of the non-mutated enzyme in the same buffer.

IPC Classes  ?

  • C12N 9/22 - Ribonucleases
  • C12Q 1/34 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
  • C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
  • C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
  • C12Q 1/44 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase

92.

High Fidelity Restriction Endonucleases

      
Application Number 17227799
Status Pending
Filing Date 2021-04-12
First Publication Date 2021-07-29
Owner New England Biolabs, Inc. (USA)
Inventor
  • Zhu, Zhenyu
  • Quimby, Aine
  • Xu, Shuang-Yong
  • Guan, Shengxi
  • Wei, Hua
  • Zhang, Penghua
  • Sun, Dapeng
  • Chan, Siu-Hong

Abstract

Compositions and methods are provided for enzymes with altered properties that involve a systematic approach to mutagenesis and a screening assay that permits selection of the desired proteins. Embodiments of the method are particularly suited for modifying specific properties of restriction endonucleases such as star activity. The compositions includes restriction endonucleases with reduced star activity as defined by an overall fidelity index improvement factor.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12N 9/22 - Ribonucleases
  • C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)

93.

PAQCI

      
Application Number 1602659
Status Registered
Filing Date 2021-05-20
Registration Date 2021-05-20
Owner New England Biolabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Enzymes for scientific and research use; kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; enzymes for scientific and research use in the field of molecular biology and cell biology applications.

94.

Compositions and methods for analyzing modified nucleotides

      
Application Number 17181351
Grant Number 11939628
Status In Force
Filing Date 2021-02-22
First Publication Date 2021-07-08
Grant Date 2024-03-26
Owner New England Biolabs, Inc. (USA)
Inventor
  • Vaisvila, Romualdas
  • Davis, Theodore B.
  • Guan, Shengxi
  • Sun, Zhiyi
  • Ettwiller, Laurence
  • Saleh, Lana

Abstract

5hmC in a DNA.

IPC Classes  ?

  • C12Q 1/6827 - Hybridisation assays for detection of mutation or polymorphism
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 9/78 - Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
  • C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

95.

FCE mRNA capping enzyme compositions, methods and kits

      
Application Number 17160256
Grant Number 11028379
Status In Force
Filing Date 2021-01-27
First Publication Date 2021-06-08
Grant Date 2021-06-08
Owner New England Biolabs, Inc. (USA)
Inventor
  • Ganatra, Mehul
  • Chan, Siu-Hong
  • Taron, Christopher H.
  • Robb, G. B.

Abstract

The present disclosure relates to compositions, kits, and methods of making RNA vaccines having an appropriate cap structure. Systems, apparatus, compositions, and/or methods may include and/or use, in some embodiments, non-naturally occurring single-chain RNA capping enzymes. In some embodiments, an RNA capping enzyme may include an FCE variant having (a) an amino acid sequence at least 90% identical to positions 1 to 878 of SEQ ID NO: 1, and/or (b) one or more substitutions relative to SEQ ID NO: 1 at a position selected from positions corresponding to positions 215, 337, 572, 648, and 833 (e.g., a position selected from positions corresponding to position 215, 337, and 572) of SEQ ID NO: 1.

IPC Classes  ?

  • C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
  • C12N 7/00 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 9/10 - Transferases (2.)
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/245 - Herpetoviridae, e.g. herpes simplex virus

96.

Method for removing and/or detecting nucleic acids having mismatched nucleotides

      
Application Number 16616631
Grant Number 11371088
Status In Force
Filing Date 2018-06-11
First Publication Date 2021-06-03
Grant Date 2022-06-28
Owner New England Biolabs, Inc. (USA)
Inventor Gardner, Andrew F.

Abstract

Provided herein, among other things, are various in vitro methods that involve cleaving dsDNA molecules that comprise a mismatched nucleotide using EndoMS. In some embodiments, the method may comprise ligating a T-tailed double-stranded adapter to A-tailed double-stranded fragments of nucleic acid to produce ligation products that comprise adapter-ligated fragments and double-stranded adapter dimers that comprise a T:T mismatch at the ligation junction and cleaving both strands of the adapter dimers using EndoMS.

IPC Classes  ?

  • C12Q 1/6855 - Ligating adaptors
  • C12N 9/22 - Ribonucleases
  • C12N 9/00 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
  • C12Q 1/6874 - Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation [SBH]

97.

Variant DNA polymerases having improved properties and method for improved isothermal amplification of a target DNA

      
Application Number 17156704
Grant Number 11371028
Status In Force
Filing Date 2021-01-25
First Publication Date 2021-05-27
Grant Date 2022-06-28
Owner New England Biolabs, Inc. (USA)
Inventor
  • Ong, Jennifer
  • Tanner, Nathan
  • Zhang, Yinhua
  • Bei, Yanxia
  • Potapov, Vladimir

Abstract

Variants of the bacteriophage B103 DNA polymerase are described herein. The variant has improved properties, that include when compared to wild-type Phi29 DNA polymerase, at least one of the following: increased thermostability, improved reaction rate for DNA amplification, reduced background and a reduction of bias. Methods of using the DNA polymerase variant are also described herein.

IPC Classes  ?

  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N 7/00 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

98.

PAQCI

      
Application Number 212098400
Status Registered
Filing Date 2021-05-20
Registration Date 2023-11-08
Owner New England Biolabs, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

(1) Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; enzymes for scientific and research use in the field of molecular biology and cell biology applications

99.

Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity

      
Application Number 16616734
Grant Number 11376338
Status In Force
Filing Date 2018-06-12
First Publication Date 2021-05-20
Grant Date 2022-07-05
Owner New England Biolabs, Inc. (USA)
Inventor
  • Roy, Bijoyita
  • Robb, G. B.

Abstract

Provided herein, among other things, is a method for producing an RNA product that has reduced immunogenicity. In some embodiments, the method involves transcribing a template DNA with a thermostable RNA polymerase at a temperature of greater than 44° C.

IPC Classes  ?

  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
  • C12P 19/34 - Polynucleotides, e.g. nucleic acids, oligoribonucleotides
  • A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
  • C12N 9/12 - Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

100.

Rapid diagnostic test using colorimetric LAMP

      
Application Number 17122979
Grant Number 11008629
Status In Force
Filing Date 2020-12-15
First Publication Date 2021-05-18
Grant Date 2021-05-18
Owner New England Biolabs, Inc. (USA)
Inventor
  • Tanner, Nathan
  • Zhang, Yinhua
  • Patton, Gregory
  • Ren, Guoping
  • Li, Zhiru
  • Nichols, Nicole

Abstract

Kits and methods are provided for performing multiplex LAMP reactions. These kits and methods are directed to specific and sensitive methods of target nucleic acid detection and more specifically pathogen diagnostics such as detection of Coronavirus. The kits and methods utilize a plurality of sets of oligonucleotide primers for targeting the viral nucleic acid target.

IPC Classes  ?

  • G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
  1     2     3     ...     5        Next Page